Prospective Trial of IVL for Calcified Carotid Lesions(CREATE Trial)

NARecruitingINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

May 12, 2025

Primary Completion Date

December 30, 2027

Study Completion Date

December 30, 2027

Conditions
Carotid Artery Stenosis
Interventions
DEVICE

Neurovascular Intravascular Shockwave Catheter

"Device:~Neurovascular Intravascular Shockwave Catheter (single-use, rapid-exchange balloon catheter with integrated shockwave emitters).~Intravascular Shockwave Therapy Device (IVL-HVG-N01, generates localized shockwaves to fracture calcifications).~Procedure:~Patients undergo standard CAS preparation with guidewire placement and cerebral protection.~If conventional balloon angioplasty fails (residual stenosis \>70%), the IVL catheter is advanced to the target lesion.~Shockwave therapy is applied at 6 atm, followed by low-pressure balloon dilation (8 atm) if needed.~Subsequent stent deployment is performed per standard practice."

Trial Locations (1)

Unknown

RECRUITING

Beijing An Zhen Hospital of the Capital University of Medical Sciences, Beijing

All Listed Sponsors
lead

Shanghai Bluesail Boyuan Medical Technology Co., Ltd.

INDUSTRY